http://hotcopper.com.au/threads/201....2435241/page-8?post_id=14547108#.VLGdH8scSsE
Above are HC links to 3 who consider additional trials will be needed before BT is granted.
Steve Kaminsky the CSO of Rettsyndrome.org
Dr Alan Percy, Professor of Pediatrics, Neurology, Neurobiology, Genetics, and Psychology at the University of Alabama in Birmingham, was an investigator for the Neuren Retts study.
Dr Michael Tranfaglia medical director who is from Fraxa
To this I add a 4th.
"If the results of the Phase 2 trial are positive, we intend to request an end of Phase 2 meeting with FDA to discuss requirements for a pivotal trial and registration under provisions of Fast Track and potentially Breakthrough Therapy designation. We are expecting that a pivotal trial would be same size as the Phase 2 trial and could be completed within one year."
Larry Glass
20 May 2013
- Forums
- ASX - By Stock
- NEU
- FDA decision within 1-50 days
FDA decision within 1-50 days, page-22
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.05 |
Change
0.000(0.00%) |
Mkt cap ! $1.795B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 102 | $14.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.24 | 479 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 13.990 |
1 | 300 | 13.970 |
1 | 1432 | 13.950 |
2 | 1230 | 13.900 |
1 | 720 | 13.890 |
Price($) | Vol. | No. |
---|---|---|
14.420 | 175 | 1 |
14.500 | 2985 | 2 |
14.800 | 2850 | 2 |
14.860 | 500 | 1 |
14.960 | 445 | 1 |
Last trade - 09.54am 07/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable